• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Molecular Diagnostics Market

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Microbiology, Genetic Disease Screening, Blood Screening, Others), By Product (Instruments, Reagent, Software & Services), By End User (Hospitals, Blood Banks, Research Laboratories and Others), By Technology (In-Situ Hybridization, DNA Sequencing, PCR, Chips and Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT) and Others) - Global Forecast till 2025

  • Published Date : 04 Jun 2018
  • Reports Monitor
  • Category : Medical Devices
  • Pages : N/A

Market Scenario:
Molecular diagnostics is referred as the laboratory tests used to detect and identify the presence of genetic material associated with health condition or disease by examining their proteins levels, DNA (deoxyribonucleic acid), RNA (ribonucleic acid). These tests are commonly performed on samples of blood and tumour tissue. Such diagnostics test provides important insights at every stage of the disease such as prevention of disease, detection, and successful treatment plan. Molecular diagnostic is a subset of in-vitro diagnostics. Molecular diagnostic refers to a tool to increase the efficiency of clinical outcomes and treatment decisions. Nowadays, such diagnostics tests are performed for the early detection of infectious diseases, genetic disorder and cancer with the use of genetic and molecular technologies. Molecular diagnostics is widely used in the area of cancer treatment plan. Such tests have the provision of differentiating cancer from benign tumors (i.e., growths of cells that are on initial stages and not harmful) and can further provide insights to detect the type of tissue in which cancer originated including breast, skin, and lung. Molecular diagnostics helps to provide critical insight to classify different cancer subtypes that affect the same tissue. For example, blood cancer is also called as acute myelogenous leukemia (AML) and can be bifurcated into poor and intermediate types, based on critical examining of chromosomes.

According to the American Cancer Society report, there will be around 1.7 million new cases of cancer diagnosed in the United States and approximately 609,640 Americans will die from the cancer in 2018. Moreover, according to the American Cancer Society epidemiologists, in 2018, there are approximately 42% new registered cancer cases, which imply around 729,000 cases of the newly diagnosed cancers in the U.S. Out of which, 19% cases are triggered by smoking and 18% cases are caused by several factors which includes physical inactivity, excess alcohol consumption, combination of excess body weight, and poor nutrition. Certain cancers are caused due to the spread of infectious agents which includes hepatitis B virus (HBV), hepatitis C virus (HCV), human papillomavirus (HPV) and Helicobacter pylori (H. pylori).

Rising prevalence of cancer owing to the exposure to harmful radiation and unhealthy dietary habits, physical inactivity and increasing geriatric population have added to the growth of molecular diagnostics market. Moreover, successful prognosis of a wide range of contagious diseases including HIV and hepatitis and growing demand for biomarkers for conducting diagnosis test have been the significant factors in charge of fuelling the demand in the market. In addition, increasing demand for point of care diagnostic technologies (POCT) and next generation sequencing (NGS) have propeled the market growth. However, stringent regulation of U.S. FDA approval for molecular diagnostic technology, lack of well-defined guidelines associated with molecular diagnostic test in emerging countries, and high cost of diagnostics test may hamper the growth of the market. On the other hand, advancement of technology in the area of Genomics and Proteomics will provide the opportunity for the expansion of the market.

Regional Analysis:
Geographically, the molecular diagnostics market can be analysed into North America, Europe, Asia Pacific, and LAMEA. North-America is expected to be dominant in the market by following factors, which include advancements in the field of molecular diagnostics, increasing application of blood-screening, growing awareness associated with cancer disease, and well-established diagnostic infrastructure. The Asia-Pacific market is expected to be driven by factors including the development of health-care infrastructure, high adoption of new technology and medical devices, presence of a large target population, and unmet clinical needs.

Key Players:
Major key players in the market are Novartis AG, Roche Diagnostics, Siemens Healthcare, Abbott Laboratories Inc., QIAGEN, Cepheid Inc., Beckman Coulter Inc., Myriad Genetics Inc., bioMerieux, Gen-Probe Inc. (Hologic Inc.), Becton, and Dickinson and Company among others.

Competitive Intelligence:
FoundationOne CDx™ was approved by US Food and Drug Administration (FDA). FoundationOne is the pan-tumour comprehensive companion diagnostic assay for personalised oncology care. This diagnostic assay identifies patients with advanced cancer and assesses all four classes of genomic changes in 324 genes which helps physician to decide therapies accordingly.

Segmentation:
By Application    
                     

  • Infectious Disease              
  • Oncology
  • Microbiology
  • Genetic Disease Screening
  • Blood Screening 
  • Others 

By Product                     

  • Instruments
  • Reagent
  • Software & Services      

By End User                           

  • Hospitals
  • Blood Banks
  • Research Laboratories   
  • Others

By Technology

  • In-Situ Hybridization
  • DNA Sequencing
    • Next Generation Sequencing (NGS)
    • Capillary Electrophoresis (CE)
  • PCR
  • Chips and Microarray
  • Isothermal Nucleic Acid Amplification Technology (INAAT)
  • Others

									

	

Related Reports

Dental Diagnostics and Surgical Equipment Market Outlook and Company Analysis-Global Forecast to 2025

The Global dental diagnostic and surgical equipment market is anticipated to exceed US$ 3 Billion by 2025, growing at a CAGR of over 6% between 2018 and 2025. The dental diagnostics and surgical equip ...read more

Global Sinus Dilation Devices Market Study and Trend Research 2015-2025

Snapshot Chronic sinusitis affects more than 31 million people in the United States. It is more prevalent than heart disease and asthma and has a greater impact on patients’ quality of life than chr ...read more

Global Venous Stents Market Report 2018

with the slowdown in world economic growth, the Venous Stents industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Venous Stents marke ...read more

Global Spinal Trauma Devices Market Report 2018

with the slowdown in world economic growth, the Spinal Trauma Devices industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Spinal Trau ...read more

Global Self-Monitoring Blood Glucose (SMBG) Devices Market Report 2018

with the slowdown in world economic growth, the Self-Monitoring Blood Glucose (SMBG) Devices industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.